PMS-SITAGLIPTIN TABLET
国家: 加拿大
语言: 英文
来源: Health Canada
产品特点
(SPC)
14-12-2021
该产品的某些文档当前不可用，您可以向我们的客户服务发送请求，我们将在获得它们后尽快通知您。
发送请求。
发送请求。
有效成分:
SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE)
可用日期:
PHARMASCIENCE INC
ATC代码:
A10BH01
INN（国际名称）:
SITAGLIPTIN
剂量:
25MG
药物剂型:
TABLET
组成:
SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 25MG
给药途径:
ORAL
每包单位数:
100
处方类型:
Prescription
產品總結:
Active ingredient group (AIG) number: 0152414002; AHFS:
授权状态:
APPROVED
授权日期:
2023-01-05
产品特点
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
Prpms -SITAGLIPTIN
Sitagliptin Tablets
Tablets, 25, 50 and 100 mg sitagliptin (as sitagliptin phosphate monohydrate) Oral
House Standard
Dipeptidyl peptidase 4 (DPP -4) inhibitors
PHARMASCIENCE INC
6111 Royalmount Ave., Suite 100
Montréal, Canada
H4P 2T4
Date of Initial Authorization:
August 18, 2020
Date of Revision:
December 14, 2021
www.pharmascience.com
Submission Control Number: 254974
阅读完整的文件
